AMINO I
Natural health product licensed in Canada
- Licence holder
- 9231-6124 Québec Inc.
- NPN or DIN-HM
- 80106540
- Status
- Active licence
- Licence date
- 26 November 2020
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Saveur, Maltodextrine, Citrate de trisodium, Acide citrique anhydre, Extrait de feuilles de stévia
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Aide temporairement à favoriser la vigilance et l'état d'éveil et à améliorer la performance intellectuelle. Aide temporairement à soutenir/favoriser la clarté mentale/vigilence. Aide à soutenir la santé cognitive. SOURCES D'ACIDES AMINÉS BRANCHÉS, JOUANT UN RÔLE DANS LA SYNTHÈSE DES PROTÉINES. SOURCE D'ACIDES AMINÉS ESSENTIELS JOUANT UN RÔLE DANS LA SYNTHÈSE DES PROTÉINES MUSCULAIRES. AIDE À DÉVELOPPER LA MASSE MUSCULAIRE LORSQU'UTILISÉ EN ASSOCIATION AVEC UN ENTRAÎNEMENT RÉGULIER ET UNE DIÈTE ÉQUILIBRÉE.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Cesser l'utilisation si une hypersensibilité/allergie se manifeste. Peut causer des problèmes digestifs.
Source
Official Health Canada record, licence 80106540
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.